Drug Type Small molecule drug |
Synonyms |
Target |
Action agonists |
Mechanism TGR5 agonists(G-protein coupled bile acid receptor 1 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC28H49NNaO6S |
InChIKeyUIXKWNINXABQFM-UKWCPTHLSA-N |
CAS Registry3027426-02-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammation | Preclinical | New Zealand | 25 Jan 2023 | |
Liver Diseases | Preclinical | New Zealand | 25 Jan 2023 | |
Metabolic Diseases | Preclinical | New Zealand | 25 Jan 2023 | |
Neurodegenerative Diseases | Preclinical | New Zealand | 25 Jan 2023 |